Sun Pharma Advanced Research Company Limited announced earnings results for the first quarter ended June 30, 2021. For the first quarter, the company announced total revenue was INR 227.9 million compared to INR 1,861.1 million a year ago. Net loss was INR 613.7 million compared to net income of INR 566.9 million a year ago. Basic loss per share from continuing operations was INR 2.34 compared to basic earnings per share from continuing operations of INR 2.16 a year ago.